Strenghtening collaboration with Serbia - IPA4 Project expected outcomes Frédéric Denecker, Programme Management Officer Reitox and International Cooperation.

Slides:

Advertisements

Similar presentations

TREATMENT DATA INDICATORS IN THE UNODC DATA COLLECTION SYSTEM.

Advertisements

The EMCDDA and the Reitox network: towards quality achievement Sandrine Sleiman, Scientific Committee, Palmela, February 2008.

Western Balkans and Europe 2020 Western Balkans and Europe 2020 Towards Convergence and Growth – Draft Conclusions Brussels, March 2011.

Sarajevo, October 17,   The institution of the Unit was in line with the strategy adopted by the Italian Government in the Region and its work.

Overview of the 2011 Work Programme Paul Griffiths Scientific committee meeting, Lisbon, November 2010.

EMCDDA Technical Cooperation Activities “ Perspectives for the future” Frédéric Denecker Reitox Network and Project Support Officer.

2 emcdda.europa.eu European drug report package A comprehensive analysis on the drugs problem in Europe.

Primeri evaluacije poljske Strategije za borbu protiv droga: nacionalne i regionalne perspektive Dr Piotr Jablonski National Bureau for Drug Prevention.

Overview of the 2010 work programme Paul Griffiths, Roland Simon, Rosemary de Sousa Scientific Committee meeting, Lisbon, November 2009.

THE EU FRAMEWORK FOR INTEGRATION Didier Boone BE National Contact Point on Integration to the European Commission Brussels Regional Parliament - June 8th.

Progress in PRS Implementation: The Republic of Serbia Presented by Ivana Aleksić, Team Manager Poverty Reduction Strategy Implementation Focal Point Deputy.

Drug use, related problems and interventions targeting drug users in prison in the European countries: main issues and challenges for the future Linda.

Information needs for effective drug policy in the programme of the CZ PRES Identifying Europe’s information needs for effective drug policy Lisbon /

The REITOX Experience Lessons learned in developing a network of National Drugs Focal Points and challenges for the future Alan Lodwick, Head of UK National.

European Monitoring Centre for Drugs and Drug Addiction Margareta Nilson ISAJE, Helsinki, 1 September 2006.

The UK Drugs Situation: Data, information and uses Charlotte Davies, UK Focal Point Project Manager 1.

Tim Pfeiffer-Gerschel, DBDD Dubrovnik, Jan 2008CARDS EWS CARDS 2004, Component 4 Early Warning System Tim Pfeiffer-Gerschel National Focal Point.

An EMCDDA view on recovery Roland Simon Head of Unit Intervention, Best Practice, and Scientific Partners.

Quality Assurance at the European Monitoring Centre for Drugs and Drug Addiction Sandrine Sleiman European Conference on Quality in Official Statistics,

UNDP Support to UN Cooperation in Moldova Annual Programme Review UNDP Moldova 18 December, 2003.

Programming of International Development Assistance Donor Meeting Agency for Human and Minority Rights September 27, 2007.

Jennifer Hillebrand, „Rehabilitation of Drug Addicted Persons: Experience of Lithuania and European Countries”, 18 October 2007 Improving drug treatment.

Annual report 2010: the state of the drugs problem in Europe.

Community agencies: partners in accession Cooperation with EMCDDA - Polish experience Boguslawa Bukowska, National Bureau for Drug Prevention ,

Marina Kuzman, MD, PhD Croatian National Institute of Public Health National Drug Prevention and Information System in the Republic of Croatia - impact.

(Dr. Peter Heil, ALTUS – Hungary)

Joanna Fiedler Enlargement and Neighbouring Countries Unit DG Environment European Commission REReP → RENA Vision of the European Commission PEIP Regional.

1 European Union Regional Policy – Employment, Social Affairs and Inclusion The new architecture for cohesion policy post-2013 High-Level Meeting on the.

European Commission Introduction to the Community Programme for Employment and Social Solidarity PROGRESS

EUROPEAN COMMISSION DG Employment, Social Affairs and Equal Opportunities Luca PIROZZI Social Protection and Inclusion Policies PROGRESS Community Programme.

Revision of Problem Drug Use indicator Danica Klempová and Julián Vicente 42nd Reitox HFP meeting, 27 May 2010.

Presentation of EU Drug Strategy and Action Plan – current status. Evaluation of previous EU Strategy. Dr Piotr Jablonski National Bureau for Drug Prevention.

Paul Griffiths and Roland Simon Wrap-up presentation What has the EMCDDA learned ?

Africa Health Workforce Platform & Observatory Presentation to the 1st conference of the Asia-Pacific Action Alliance on HRH (AAAH): October 2006.

Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.

A Strategic Research Agenda for Europe in the field of illicit drugs Priorities for socio-economic and humanities research HDG Brussels - December 10,

Lisbo n, Novem b er Bosnia and Herzegovina Ministry of Civil Affairs Sector for Health COMMUNITY AGENCIES: PARTNERS IN ACCESSION The point.

Linda Montanari, Buenos Aires, October 2003 CICAD/OAS, Demand Reduction Experts Group Meeting The Information System on Treatment Demand in EU EMCDDA.

EMCDDA Work Programme Key Issue 1: Key Indicators 30th Meeting of Scientific Committee J Vicente (together with D Olszewski, D Klempova, L Montanari,

Jovan TEGOVSKI Chief of Staff 10 October 2011, Skopje 2 nd Meeting of the European Forum for Disaster Risk Reduction (EFDRR) The role of the Regional Cooperation.

KAJ MORTENSEN, HEAD OF SAPARD UNIT, DG AGRI EUROPEAN COMMISSION Pre-accession Assistance for Rural Development.

Stabilisation & Association Process: the EU Policy for South East Europe Brussels December 2004.

The industrial relations in the Commerce sector EU Social dialogue: education, training and skill needs Ilaria Savoini Riga, 9 May 2012.

The Point of View of a Candidate Country Dr. Peyman Altan Ministry of Health of Turkey November 2009 Lisbon.

Changes in the context of evaluation and assessment: the impact of the European Lifelong Learning strategy Romuald Normand, Institute of Education Lyon,

DG Enlargement – Effective Support for Enlargement Conference, Brussels 19 October 2009 Concluding Remarks of the Co-chairs.

The ERA-NET TRANSCAN-2, in continuity with the preceding ERA-NET TRANSCAN, aims at linking translational cancer research funding programmes in 15 Member.

Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.

Overview of EMCDDA’s 2009 Scientific Work Programme Paul Griffiths, Roland Simon - REITOX Meeting, Lisbon, November 2007.

Overview of the three-year work programme (2010–2012) Rosemary de Sousa, Roland Simon, Paul Griffiths 30th ScC meeting, June 2009.

BULGARIA’S EXPERIENCE WITH REGIONAL COOPERATION IN SOUTH-EAST EUROPE Veneta Petrova National Statistical Institute of Bulgaria MGSC, March 2011,

EMCDDA Treatment data collection strategy - progress report May 09 Dagmar Hedrich, on behalf of the TWG Presentation at the meeting of the Scientific Committee,

Matthias Wentzlaff-Eggebert, BZgA This work is part of the Joint Action on Improving Quality in HIV Prevention (Quality Action), which has received funding.

Monitoring and reporting on the drug phenomenon in Europe EMCDDA mandate and activities Wolfgang Götz, Scientific Committee, Palmela, 14 February 2008.

Paul Cook Looking out from the EMCDDA Regional systems in a global perspective Lisbon 8 th May 2009.

First European conference on drug supply indicators, , Brussels – Feed-back Chloé Carpentier, Laurent Laniel, EMCDDA 33 rd meeting of the.

Annual report 2012: the state of the drugs problem in Europe Name, date.

Collaboration between the national EWS and treatment service providers in Hungary Anna Péterfi Hungarian National Focal Point TAIEX seminar Zagreb,

African Centre for Statistics United Nations Economic Commission for Africa Session 2 How to meeting countries needs: What has been done and way forward.

SOCIAL INCLUSION IN EASTERN EUROPE AND CENTRAL ASIA TOWARDS MAINSTREAMING AND RESULTS SOCIAL INCLUSION IN EASTERN EUROPE AND CENTRAL ASIA TOWARDS MAINSTREAMING.

PLANNED ACTIONS – UPCOMING DUTIES

Quality assurance : state of progress

CLOE: A successful pilot project

Introduction to the training

Strategy for statistical cooperation with the enlargement countries 2014 – 2020 MGSC March 2014 Point 3.1 of the Agenda Ferenc Gálik.

Statistics in the Enlargement context

Marleen De Smedt Geoffrey Thomas Cynthia Tavares

NDPHS Progress Report for 2009

Communication and publications

Skopje, 21 November 2017, General Population Survey results– launch

Presentation transcript:

Strenghtening collaboration with Serbia - IPA4 Project expected outcomes Frédéric Denecker, Programme Management Officer Reitox and International Cooperation Unit Belgrade, 22 November 2012

2 emcdda.europa.eu Building on past and present, towards future IPA 3 project - experience and outcomes in Serbia IPA 4 project - specific objectives and expected outcomes Twinning project - streamlining of activities and avoiding overlap

3 emcdda.europa.eu Information available through IPA cooperation Drug situation: First National report Country overview ESPAD survey Data collection tools: Information map National Action Plan for Drug information system (NAPDIS) Translated EPI Key Indicators protocols

4 emcdda.europa.eu Activites under IPA 3 in Serbia Successful establishment of a working group for drafting fist national report & documents Specific support from Cypriot Reitox NFP Increased visibility of the information from Serbia Availability of reference documents in national language (EMCDDA protocols on KI, guidelines on harm reduction,…)

5 emcdda.europa.eu Activites under IPA 3 in Serbia Regional Reitox Academies on: Drug-related death indicator (Skopje) National reporting (Lisbon) Early Warning system (Tirana) Exchanges with EU experts at meetings and study visit to Cyprus

6 emcdda.europa.eu EMCDDA-IPA 4 project January 2012 – November 2014 Overall budget: € The project is financed through the Instrument of Pre-accession Assistance (IPA) of DG Enlargement of the European Commission Implemented an coordinated by the EMCDDA, in close collaboration with Reitox Focal Points and EU experts

7 emcdda.europa.eu Areas for future collaboration: Epidemiology GPS (incl. school surveys) - possible methodological support for pilot survey - possible co-financing for data collection - continuous support for ESPAD, dissemination of results PDU - methodological support for further development of PDU (so far only IDU estimation is available) TDI - Increase participation of treatment centres to data collection and sharing protocol DRID - methodological support for data collection and for data analysis DRD - Support to involved institutions to improve data collection

8 emcdda.europa.eu Areas for future collaboration: Policy & interventions- best practices Reitox academy in October “Monitoring and evaluation of national drug strategies” (Riga) Interest on methods for estimates of Public expenditures Prevention Dissemination of information on standards for prevention-focus on indicated and selective Harm reduction Support for monitoring interventions including in prisons; dissemination of the joint EMCDDA-ECDC guidelines on prevention of infections

9 emcdda.europa.eu Areas for future collaboration: Supply reduction and new trends New substances appearing at EU level Domestic cultivation reported in all European countries New indicators being negotiated at EU level

10 emcdda.europa.eu Areas for future collaboration: Building an integrated system Ad-hoc support to National Focal Building Update of the information map Update of the NAPDIS (in view of its official adoption ?) Coordination mechanisms for exchange of data Roadmap for EMCDDA accession

11 emcdda.europa.eu IPA 4: common activities to all beneficiaries 1. Mandatory outputs to be improved with support of EMCDDA feedback: country overview, national report, information map, NAPDIS and EMCDDA Roadmap. 2. Contribution to a regional publication at the end of project 3. Participation at: - Extended Reitox Week (May) - Selected Epidemiological key indicators meetings - Early Warning System experts meeting - Reitox Academy Training activities: - EU affairs (Jan 2013) - National data reporting (Feb-March 2013) - Spring University School (April 2013) - IPA4 project coordination meetings

12 emcdda.europa.eu IPA 4: Milestones

13 emcdda.europa.eu IPA 4: immediate next steps Discussion on joint activities and priorities for cooperation Endorsement of the work programme at national level Re-activation national working group/-s Streamlining of activities with Twinning project

14 emcdda.europa.eu Resources always available Annual report Drugnet Europe Country overviews Statistical bulletin

15 emcdda.europa.eu Looking at the bigger picture Main conclusions from 2012 EMCDDA AR: Europe has a more stable drug use situation (e.g. further signs of falling use and status of cocaine) Complex stimulant market and plethora of powders and pills (i.e. fast moving, volatile market - difficult to control), incl. new trafficking routes and record number of online shops selling ‘legal highs’ Important to improve understanding of health and social impact of emerging trends and to develop measures to reduce demand Investment in treatment and harm reduction has proved successful but still room for progress in prevention, social reintegration, prisons Recession - impact on Europe’s drug problems and responses?

16 emcdda.europa.eu Thank you for your attention!